Not Tagged
Not Tagged
['melanoma']
$evax presented clinical data from its evx-01 phase 1 dose escalation trial in metastatic melanoma at the 2023 asco annual meeting in chicago, illinois. the phase 1 trial successfully met primary endpoints for safety and tolerability of evx-01 in metastatic melanoma patients and 
FDA catalyst calendar, newsletters, and more. We do not provide investment advice or recommendations. #biotech #stocks